Evidence map›Paper›PMID 34576233›Full record

ArticleInternational journal of molecular sciences2021

Study on Maximum Specific Loss Power in Fe

Costica Caizer, Isabela Simona Caizer

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Special Issue on Nanoparticles in Nanobiotechnology and Nanomedicine.International journal of molecular sciences · 2024
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Nanomaterials in Cancer Diagnosis and Therapy.International journal of molecular sciences · 2022
    Article
  7. Review
  8. FeNanomaterials (Basel, Switzerland) · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Costica CaizerDepartment of Physics, Faculty of Physics, West University of Timişoara, 300223 Timişoara, Romania.
Isabela Simona CaizerDepartment of Physics, Faculty of Physics, West University of Timişoara, 300223 Timişoara, Romania.
Victor Babeș University of Medicine and Pharmacy Timișoara · ROWest University of Timişoara · RO

Funding

West University of Timisoara university research
6 · The paper itself

Abstract

Different chemical agents are used for the biocompatibility and/or functionality of the nanoparticles used in magnetic hyperthermia to reduce or even eliminate cellular toxicity and to limit the interaction between them (van der Waals and magnetic dipolar interactions), with highly beneficial effects on the efficiency of magnetic hyperthermia in cancer therapy. In this paper we propose an innovative strategy for the biocompatibility of these nanoparticles using gamma-cyclodextrins (γ-CDs) to decorate the surface of magnetite (Fe

Indexed as

Biocompatible MaterialsCell Line, TumorFerric Compoundsgamma-CyclodextrinsHumansHyperthermia, InducedMagneticsMagnetite NanoparticlesMetal NanoparticlesNeoplasmsX-Ray DiffractionBiocompatible MaterialsFerric Compoundsferric oxidegamma-cyclodextringamma-CyclodextrinsMagnetite Nanoparticlesalternative cancer therapyBrown relaxationmagnetite nanoparticlesmaximum specific loss powerNéel magnetic relaxationsuperparamagnetic hyperthermiaγ-cyclodextrins

Identifiers

PMID34576233
PMCPMC8470897
OpenAlexW3199985206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.